Disclosure Of Interests In Other Entities [Text Block]

Sopharma Trading AD - Filing #6022492

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Non-current assets
168,393,000.000 BGN
178,510,000.000 BGN
Current liabilities
400,557,000.000 BGN
443,447,000.000 BGN
Non-current liabilities
97,402,000.000 BGN
96,144,000.000 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
- BGN
8,050,000.000 BGN
8,050,000.000 BGN
11,476,000.000 BGN
- BGN
11,476,000.000 BGN
- BGN
- BGN
- BGN
- BGN
Comprehensive income
- BGN
- BGN
- BGN
8,000.000 BGN
87,000.000 BGN
7,962,000.000 BGN
8,041,000.000 BGN
11,408,000.000 BGN
- BGN
11,417,000.000 BGN
9,000.000 BGN
- BGN
- BGN
- BGN
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
- BGN
- BGN
- BGN
8,000.000 BGN
87,000.000 BGN
88,000.000 BGN
9,000.000 BGN
68,000.000 BGN
- BGN
59,000.000 BGN
9,000.000 BGN
- BGN
- BGN
- BGN
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
11,694,000.000 BGN
7,275,000.000 BGN
Other current financial liabilities
6,370,000.000 BGN
36,591,000.000 BGN
Depreciation and amortisation expense
28,554,000.000 BGN
20,040,000.000 BGN
Tax expense (income)
1,387,000.000 BGN
2,446,000.000 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.